Standout Papers
Immediate Impact
58 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Gut microbiota-derived short-chain fatty acids and their role in human health and disease
2025 Standout
Works of Ya‐Wen Hung being referenced
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
2022 Standout
Real-world experience of pembrolizumab plus lenvatinib in unresectable hepatocellular carcinoma in Taiwan.
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ya‐Wen Hung | 142 | 92 | 80 | 111 | 10 | 289 | |
| Shana White | 60 | 60 | 50 | 101 | 8 | 253 | |
| Patrick Pham | 47 | 52 | 120 | 68 | 13 | 271 | |
| F. Chapel | 172 | 178 | 36 | 30 | 15 | 318 | |
| Junyan Feng | 51 | 62 | 121 | 23 | 8 | 233 | |
| Amy Collinsworth | 53 | 56 | 35 | 49 | 14 | 287 | |
| Lina Jiang | 33 | 50 | 63 | 29 | 13 | 260 | |
| Peng Wang | 17 | 40 | 58 | 66 | 19 | 228 | |
| Danielle E. Engler | 19 | 65 | 97 | 65 | 11 | 332 | |
| Bernard Fischbach | 48 | 47 | 148 | 19 | 16 | 301 | |
| Pavandeep Ghataorhe | 20 | 35 | 76 | 16 | 9 | 326 |
All Works
Loading papers...